0001883850-22-000022.txt : 20220330 0001883850-22-000022.hdr.sgml : 20220330 20220330164209 ACCESSION NUMBER: 0001883850-22-000022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220328 FILED AS OF DATE: 20220330 DATE AS OF CHANGE: 20220330 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Landry Robert E CENTRAL INDEX KEY: 0001585160 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 22787103 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2022-03-28 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001585160 Landry Robert E 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP Finance CFO Common Stock 2022-03-28 4 M 0 1250 555.67 A 29994 D Common Stock 2022-03-28 4 F 0 1134 685.26 D 28860 D Common Stock 2022-03-28 4 M 0 1250 555.67 A 30110 D Common Stock 2022-03-28 4 F 0 1134 685.26 D 28976 D Common Stock 2022-03-28 4 M 0 4000 399.66 A 32976 D Common Stock 2022-03-28 4 F 0 3183 685.26 D 29793 D Common Stock 2022-03-28 4 M 0 4500 399.66 A 34293 D Common Stock 2022-03-28 4 F 0 3581 685.26 D 30712 D Common Stock 2022-03-28 4 M 0 3500 399.66 A 34212 D Common Stock 2022-03-28 4 F 0 2785 685.26 D 31427 D Common Stock 2022-03-29 4 S 0 54 681.9 D 31373 D Common Stock 2022-03-29 4 S 0 103 682.37 D 31270 D Common Stock 2022-03-29 4 S 0 304 683.29 D 30966 D Common Stock 2022-03-29 4 S 0 227 684.45 D 30739 D Common Stock 2022-03-29 4 S 0 176 685.58 D 30563 D Common Stock 2022-03-29 4 S 0 192 686.67 D 30371 D Common Stock 2022-03-29 4 S 0 220 687.52 D 30151 D Common Stock 2022-03-29 4 S 0 542 688.55 D 29609 D Common Stock 2022-03-29 4 S 0 205 689.33 D 29404 D Common Stock 2022-03-29 4 S 0 37 690.91 D 29367 D Common Stock 2022-03-29 4 S 0 226 691.47 D 29141 D Common Stock 2022-03-29 4 S 0 147 692.38 D 28994 D Common Stock 2022-03-29 4 S 0 103 693.18 D 28891 D Common Stock 2022-03-29 4 S 0 147 694.94 D 28744 D Common Stock 229 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 399.66 2022-03-28 4 M 0 4000 0.0 D 2024-12-16 Common Stock 4000 13000 D Non-Qualified Stock Option (right to buy) 399.66 2022-03-28 4 M 0 4500 0.0 D 2024-12-16 Common Stock 4500 8500 D Non-Qualified Stock Option (right to buy) 399.66 2022-03-28 4 M 0 3500 0.0 D 2024-12-16 Common Stock 3500 5000 D Non-Qualified Stock Option (right to buy) 555.67 2022-03-28 4 M 0 1250 0.0 D 2025-12-16 Common Stock 1250 1250 D Non-Qualified Stock Option (right to buy) 555.67 2022-03-28 4 M 0 1250 0.0 D 2025-12-16 Common Stock 1250 0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 54 shares of Company stock on March 29, 2022 at prices ranging from $681.89 to $681.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. Represents volume-weighted average price of sales of 103 shares of Company stock on March 29, 2022 at prices ranging from $682.09 to $682.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. Represents volume-weighted average price of sales of 304 shares of Company stock on March 29, 2022 at prices ranging from $683.06 to $683.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. Represents volume-weighted average price of sales of 227 shares of Company stock on March 29, 2022 at prices ranging from $684.02 to $684.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. Represents volume-weighted average price of sales of 176 shares of Company stock on March 29, 2022 at prices ranging from $685.09 to $685.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. Represents volume-weighted average price of sales of 192 shares of Company stock on March 29, 2022 at prices ranging from $686.06 to $686.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. Represents volume-weighted average price of sales of 220 shares of Company stock on March 29, 2022 at prices ranging from $687.08 to $687.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. Represents volume-weighted average price of sales of 542 shares of Company stock on March 29, 2022 at prices ranging from $688.00 to $688.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. Represents volume-weighted average price of sales of 205 shares of Company stock on March 29, 2022 at prices ranging from $689.05 to $689.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. Represents volume-weighted average price of sales of 37 shares of Company stock on March 29, 2022 at prices ranging from $690.77 to $690.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. Represents volume-weighted average price of sales of 226 shares of Company stock on March 29, 2022 at prices ranging from $691.16 to $691.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. Represents volume-weighted average price of sales of 147 shares of Company stock on March 29, 2022 at prices ranging from $692.18 to $692.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. Represents volume-weighted average price of sales of 103 shares of Company stock on March 29, 2022 at prices ranging from $693.01 to $693.36. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Robert E. Landry 2022-03-30